跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BACEQ 100 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BACEQ 100 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Approved
STANDARD
BACEQ 100 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Teva Pharma S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 9, 2021
Approval ID
d38ff06fe2aaa722
Company
Teva Pharma S.L.U.
Type
Standard
Approval Details
Approval Id
d38ff06fe2aaa722
Drug Cima Aemps Name
BACEQ 100 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG
Register Number
86246
Holder Company Name
Teva Pharma S.L.U.
Marketing Company Name
Teva Pharma S.L.U.
Authorization Date
2021-12-09
Dosage Form
SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Dose
100 mg
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Teva Pharma S.L.U.
Active Ingredients
PALIPERIDONA PALMITATO
156 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 9, 2021
Approval ID
d38ff06fe2aaa722
Type
Standard
Back to CIMA-AEMPS Approvals